Stocks & Investing
Fri, August 16, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 9, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 18, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 15, 2024
[ 12:00 AM ] - WOPRAI
Wed, April 3, 2024
[ 12:00 AM ] - WOPRAI
Tue, March 5, 2024
[ 12:00 AM ] - WOPRAI
Wed, September 6, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, August 17, 2023
[ 12:00 AM ] - WOPRAI
Wed, July 12, 2023
[ 12:00 AM ] - WOPRAI
Tue, June 20, 2023
[ 12:00 AM ] - WOPRAI
Thu, May 18, 2023
[ 12:00 AM ] - WOPRAI
Wed, April 5, 2023
[ 12:00 AM ] - WOPRAI
Fri, January 13, 2023
[ 12:00 AM ] - WOPRAI
Tue, August 23, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, June 14, 2022
[ 12:00 AM ] - WOPRAI
Wed, April 6, 2022
Tue, March 8, 2022
[ 12:00 AM ] - WOPRAI
Tue, October 19, 2021
[ 12:00 AM ] - WOPRAI
Thu, May 20, 2021
[ 12:00 AM ] - WOPRAI
Wed, July 22, 2020
[ 12:00 AM ] - WOPRAI
Thu, May 14, 2020
[ 12:00 AM ] - WOPRAI
Mon, April 13, 2020
[ 12:00 AM ] - WOPRAI
Mon, January 13, 2020 Asthika Goonewardene Maintained (STRO) at Strong Buy with Decreased Target to $15 on, Aug 16th, 2024
Asthika Goonewardene of Truist Securities, Maintained "Sutro Biopharma, Inc." (STRO) at Strong Buy with Decreased Target from $18 to $15 on, Aug 16th, 2024.
Asthika has made no other calls on STRO in the last 4 months.
There are 4 other peers that have a rating on STRO. Out of the 4 peers that are also analyzing STRO, 0 agree with Asthika's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Asthika
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $12 on, Wednesday, August 14th, 2024
- Jay Olson of "Oppenheimer" Maintained at Buy and Held Target at $10 on, Wednesday, May 15th, 2024
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $8 on, Tuesday, May 14th, 2024
- Tazeen Ahmad of "B of A Securities" Initiated at Strong Buy and Held Target at $12 on, Wednesday, May 8th, 2024
